Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment. Bulgaria, Denosumab, GE-Lunar, Glucocorticoids, Longitudinal, Osteoporosis, Secondary osteoporosis, Treatment (anti-osteoporotic treatments)
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study. France, Germany, Hologic, Osteoporosis, UK
A retrospective case-control study assessing the role of trabecular bone score in postmenopausal Caucasian women with osteopenia: analyzing the odds of vertebral fracture France, GE-Lunar, Osteoporosis
Recommendations by the Spanish Society of Rheumatology on Osteoporosis – ScienceDirect Osteoporosis, Review, Rheumatology, Spain
Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study France, Osteoporosis, Switzerland
Estimation of bone microarchitecture pattern from AP spine DXA scans using the Trabecular Bone Score (TBS): an added value in clinical routine for the patient. A short review Osteoporosis, Review
[OsteoLaus: prediction of osteoporotic fractures by clinical risk factors and DXA, IVA and TBS] France, Osteoporosis, Switzerland
Screening: Assessing bone structure in the prediction of osteoporotic fractures Osteoporosis, Review, USA
A multicentre, retrospective case-control study assessing the role of trabecular bone score (TBS) in menopausal Caucasian women with low areal bone mineral density (BMDa): Analysing the odds of vertebral fracture France, GE-Lunar, Osteoporosis
Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study Canada, GE-Lunar, Osteoporosis